Search This Blog

Tuesday, November 12, 2019

Heron Therapeutics EPS beats by $0.15, beats on revenue

Heron Therapeutics (NASDAQ:HRTX): Q3 GAAP EPS of -$0.42 beats by $0.15.
Revenue of $42.62M (+115.4% Y/Y) beats by $8.07M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)